Billionaire investor Chamath Palihapitiya files for 4 new biotech-focused SPACs that seek to raise $800 million

Chamath Palihapitiya filed for four blank-check companies on Wednesday along with a new partner, according to paperwork registered with the Securities and Exchange Commission.

The latest additions build on his roster of 6 special-purpose acquisition companies already raised, yielding more than $1 billion. 

The four new SPACs are launched under a partnership between Palihapitiya’s venture firm Social Capital and hedge fund Suvretta Capital Management. One of Suvretta’s core investing strategies is to identify companies that are disruptive to the healthcare sector .

The companies may initially pursue a combination target in any industry as part of its proposed business strategy, filings state.

Click Here To Read More…

The domain name:  Annually.com is available for purchase. Learn how you can use this domain for your business.

Get More Info